Ironwood Pharmaceuticals (irwd 1.5 06/15/26)
13F holders, Q4 2025 (December 31)1holders −2
1new positions
0sold out
$0.94avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Ironwood Pharmaceuticals (irwd 1.5 06/15/26) in their 13F filings, down 2 from Q2 2024. 1 opened new positions and 0 sold out. The largest holder was Advisory Services Network, LLC ($17K).
- Company
- Ironwood Pharmaceuticals (irwd 1.5 06/15/26)
- CUSIP
- 46333XAH1
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $17K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q4 2025: 18,000 shares bought, net +18,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Advisory Services Network, LLC | 0.00% | New | 18,000 | $17K |
"% of holder's portfolio" is IRONWOOD PHARMACEUTICALS (IRWD 1.5 06/15/26)'s weight in each manager's 13F, not the share of Ironwood Pharmaceuticals (irwd 1.5 06/15/26) the manager owns.